Chris Lo

All articles by Chris Lo

1. Amazon and PillPack: an unstoppable pharmacy force?

   The US pharmacy industry has been bracing for an Amazon-shaped avalanche for several years now. The online retail giant has…
   Read More…

   27 Sep
2. The People vs Big Pharma: tackling the industry’s trust issues

   “I sort of view Big Pharma, as an industry, as an octopus with many tentacles, and at the end of…
   Read More…

   20 Aug
3. Blocking generic competition: will naming and shaming work?

   With the US political spotlight still centred firmly on drug prices, President Donald Trump’s 11 May speech on the topic…
   Read More…

   11 Jul
4. Shaky foundations: the flaws in animal research reporting

   Animal studies represent one of the fundamental layers of modern clinical research. Preclinical testing of drug candidates on animal models…
   Read More…

   20 Jun
5. Can the gene and cell therapy revolution scale up?

   As innovative gene and cell therapies continue to make the transition from the laboratory to the clinic, they are bringing…
   Read More…

   28 May
6. CRISPR: a seismic shift in gene editing

   Given the ubiquity of CRISPR today, it’s hard to believe that the technology was little more than a blip on…
   Read More…

   23 May
7. Biotech M&A: will the 2018 surge last?

   Over the last 20 years, the pace of mergers and acquisitions (M&A) in the biotech and pharma industries seems to…
   Read More…

   14 May
8. Boosting biosimilar uptake in the US: what needs to change?

   While the debate over drug prices rages on in the US, there’s one benefit that is often trumpeted by the…
   Read More…

   2 May
9. US drug pricing: could the industry regulate itself?

   Back in September 2016, with the US presidential election in full swing and drug prices high on the public agenda,…
   Read More…

   5 Apr
10. Is a universal flu vaccine on the horizon?

    As the 2018 flu season – one of the most severe in recent years – finally shows signs of winding…
    Read More…

    13 Mar